Schorge JO - Search Results

1

Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Clark RM, Growdon WB, Wiechert A, Boruta D, Del Carmen M, Goodman AK, Bradford L, Rauh-Hain A, Schorge JO. Clark RM, et al. Among authors: schorge jo. Gynecol Oncol. 2013 Sep;130(3):407-10. doi: 10.1016/j.ygyno.2013.05.034. Epub 2013 Jun 5. Gynecol Oncol. 2013. PMID: 23747329

2

The effect of postsurgical therapy on stage III endometrial carcinoma.

Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF Jr. Schorge JO, et al. Gynecol Oncol. 1996 Oct;63(1):34-9. doi: 10.1006/gyno.1996.0274. Gynecol Oncol. 1996. PMID: 8898165

3

Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.

Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF Jr. Schorge JO, et al. Gynecol Oncol. 1997 Jul;66(1):31-5. doi: 10.1006/gyno.1997.4691. Gynecol Oncol. 1997. PMID: 9234917 Clinical Trial.

4

Stage IA1 cervical adenocarcinoma: definition and treatment.

Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Schorge JO, et al. Obstet Gynecol. 1999 Feb;93(2):219-22. doi: 10.1016/s0029-7844(98)00371-8. Obstet Gynecol. 1999. PMID: 9932559

5

Early cervical adenocarcinoma: selection criteria for radical surgery.

Schorge JO, Lee KR, Lee SJ, Flynn CE, Goodman A, Sheets EE. Schorge JO, et al. Obstet Gynecol. 1999 Sep;94(3):386-90. doi: 10.1016/s0029-7844(99)00312-9. Obstet Gynecol. 1999. PMID: 10472864

6

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

7

Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.

Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC. Schorge JO, et al. Gynecol Oncol. 2000 Mar;76(3):369-72. doi: 10.1006/gyno.1999.5711. Gynecol Oncol. 2000. PMID: 10684712

8

Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.

Schorge JO, Lee KR, Sheets EE. Schorge JO, et al. Gynecol Oncol. 2000 Aug;78(2):217-20. doi: 10.1006/gyno.2000.5857. Gynecol Oncol. 2000. PMID: 10926806 Clinical Trial.

9

Conservative management of adenocarcinoma in situ of the cervix.

Shin CH, Schorge JO, Lee KR, Sheets EE. Shin CH, et al. Among authors: schorge jo. Gynecol Oncol. 2000 Oct;79(1):6-10. doi: 10.1006/gyno.2000.5962. Gynecol Oncol. 2000. PMID: 11006022

10

Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.

Boruta DM 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Boruta DM 2nd, et al. Among authors: schorge jo. Gynecol Oncol. 2001 Apr;81(1):82-7. doi: 10.1006/gyno.2000.6118. Gynecol Oncol. 2001. PMID: 11277655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters